Remove Biomarkers Remove Kidney Disease Remove Pulmonary
article thumbnail

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25

DAIC

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

article thumbnail

Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research

DAIC

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

article thumbnail

Cardiovascular Updates from the ESC Congress 2024 

Cardiometabolic Health Congress

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Pulmonary Arterial Hypertension (PAH): Hasan Ahmad Khasawneh’s (Jordan) systematic review of Treprostinil safety in PAH patients revealed no significant increase in mortality, though adverse events were more frequent.

article thumbnail

Chest pain followed by 6 days of increasing dyspnea -- what happened?

Dr. Smith's ECG Blog

Both reperfusion, as judged by the biomarker curve, and patency, as assessed by the angiogram, were correlated with the rapidity and depth of T wave inversion. Rupture can be either free wall rupture (causing tamponade) or septal rupture, causing ventricular septal defect with left to right flow and resulting pulmonary edema and shock.